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BACKGROUND: The mechanisms governing exercise-induced angina and 
its alleviation by the most commonly used antianginal drug, nitroglycerin, 
are incompletely understood. The purpose of this study was to develop 
a method by which the effects of antianginal drugs could be evaluated 
invasively during physiological exercise to gain further understanding of 
the clinical impact of angina and nitroglycerin.
METHODS: Forty patients (mean age, 65.2±7.6 years) with exertional angina 
and coronary artery disease underwent cardiac catheterization via radial 
access and performed incremental exercise using a supine cycle ergometer. 
As they developed limiting angina, sublingual nitroglycerin was administered 
to half the patients, and all patients continued to exercise for 2 minutes at 
the same workload. Throughout exercise, distal coronary pressure and flow 
velocity and central aortic pressure were recorded with sensor wires.
RESULTS: Patients continued to exercise after nitroglycerin administration 
with less ST-segment depression (P=0.003) and therefore myocardial 
ischemia. Significant reductions in afterload (aortic pressure, P=0.030) 
and myocardial oxygen demand were seen (tension-time index, P=0.024; 
rate-pressure product, P=0.046), as well as an increase in myocardial 
oxygen supply (Buckberg index, P=0.017). Exercise reduced peripheral 
arterial wave reflection (P<0.05), which was not further augmented by 
the administration of nitroglycerin (P=0.648). The observed increases 
in coronary pressure gradient, stenosis resistance, and flow velocity did 
not reach statistical significance; however, the diastolic velocity–pressure 
gradient relation was consistent with a significant increase in relative 
stenosis severity (k coefficient, P<0.0001), in keeping with exercise-
induced vasoconstriction of stenosed epicardial segments and dilatation 
of normal segments, with trends toward reversal with nitroglycerin.
CONCLUSIONS: The catheterization laboratory protocol provides a model 
to study myocardial ischemia and the actions of novel and established 
antianginal drugs. Administration of nitroglycerin causes changes in the 
systemic and coronary circulation that combine to reduce myocardial 
oxygen demand and to increase supply, thereby attenuating exercise-
induced ischemia. Designing antianginal therapies that exploit these 
mechanisms may provide new therapeutic strategies.
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Although a common symptom and described as early as 1785,1 the exact mechanisms underly-ing exercise-induced angina are poorly under-
stood. Nitroglycerin, generally referred to as glyceryl 
trinitrate, was the first medication used for the treat-
ment of angina, described by Murrel in 1879,2 and, 
in its short-acting forms, remains first-line therapy for 
most patients today. The mechanisms by which nitrates 
are purported to exert their antianginal effect are nu-
merous, with effects on preload, afterload, and myo-
cardial perfusion being described.3–7
Despite this large body of work, the hierarchical rel-
evance of these observations and applicability to pa-
tients with coronary artery disease have been limited 
by the methods used. We developed a novel protocol 
whereby patients with coronary artery disease could 
undergo symptom-limited exercise on the catheteriza-
tion laboratory table. This enabled, for the first time, 
the immediate effects of nitroglycerin to be assessed 
with simultaneous invasive central aortic and coro-
nary hemodynamic measurements. This protocol also 
served to test the feasibility of using such a paradigm 
in the investigation of novel and established antiangi-
nal therapies.
METHODS
Study Population
Patients with symptoms of exertional angina and documented 
coronary artery disease were recruited from routine waiting 
lists for percutaneous coronary intervention at St. Thomas’ 
Hospital. Sequential patients were screened for suitability and 
recruited into 2 cohorts in a serial fashion after modification 
of the initial single-arm protocol in which all subjects received 
nitroglycerin by enrollment of a second cohort that did not 
receive nitroglycerin. Exclusion criteria were unstable symp-
toms; previous myocardial infarction in the study vessel terri-
tory; coronary artery bypass surgery; ejection fraction <50%; 
known left main stem disease; severe multivessel coronary 
artery disease or chronic total occlusions; severe renal impair-
ment; paced rhythm; left bundle-branch block; or inability to 
undertake exercise. All vasoactive medications were stopped 
48 hours before the procedure. Subjects gave written 
informed consent in accordance with the protocol approved 
by the institutional ethics committee (National Research Ethics 
Service 08/H0802/39). The study was registered with the 
National Institute for Health Research UK Clinical Research 
Network portfolio database (Central Portfolio Management 
System identifier: 7509).
Catheterization Protocol
The patient was positioned on the catheterization labora-
tory table, and the distance to the pedals of the bicycle 
ergometer was adjusted. The right arm was abducted, sup-
ported, and strapped onto a specially modified radial artery 
support so that the arm did not move during exercise. 
Patients were catheterized via the right radial artery with a 
6F sheath. Weight-adjusted heparin was administered (70 
U/kg) intra-arterially. The target artery was cannulated with 
a standard 6F guide catheter. Vasoactive substances such as 
nitroglycerin, verapamil, or sedatives were not used during 
arterial access or diagnostic angiography. A dual pressure 
and velocity sensor 0.014-in intracoronary wire (Combowire 
XT, Volcano Corp, San Diego, CA) and single pressure sensor 
0.014-in Primewire Prestige intra-aortic wire (Volcano Corp) 
were connected to the Combomap console (Volcano Corp) 
and advanced to the tip of the guiding catheter. The pres-
sure signals were then normalized. The guide catheter was 
then inserted into the coronary ostium, and the Combowire 
was advanced distal to the stenosis of the target coronary 
artery and manipulated to optimize the Doppler velocity 
trace. The guide catheter was then disengaged from the 
ostium, and the pressure wire was passed into the aortic 
root to record high-fidelity central arterial pressure. All sig-
nals were sampled at 200 Hz and stored on a disk for offline 
analysis. The raw data were extracted and imported into 
the custom-made CardiacWaves program (King’s College 
London, London, UK), which used 5-beat averaged signals 
to calculate all the metrics.
Clinical Perspective
What Is New?
• The mechanisms governing exercise-induced 
angina and alleviation by nitroglycerin are incom-
pletely understood.
• The development of a paradigm whereby patients 
with coronary artery disease can exercise while 
simultaneously having coronary and central aortic 
hemodynamics measured invasively has provided 
a unique opportunity to study these mechanisms.
• Administration of nitroglycerin ameliorates angina 
by reducing myocardial oxygen demand and 
increasing supply, with a key component being 
the reversal of exercise-induced coronary lesion 
vasoconstriction.
What Are the Clinical Implications?
• Exercising beyond the onset of ischemia is safe, and 
the adaptive changes that occur in the peripheral 
and coronary circulation are of potential benefit, 
with implications for the design of cardiac rehabili-
tation and conditioning programs in patients with 
coronary disease.
• This study highlights the importance of afterload 
reduction and the use of agents that reduce arterial 
wave reflection and promote coronary artery vaso-
dilation in the treatment of patients with exercise-
induced angina.
• Coronary artery lesion severity is a dynamic process, 
and varying degrees of lesion tone during exercise 
is a key component of patient symptomatology; 
developing strategies to evaluate this clinically may 
be of benefit.
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Exercise Protocol
Once the coronary wires were in place, baseline measure-
ments were taken before the patients underwent exercise 
on a supine bicycle ergometer. The exercise protocol was a 
standardized incremental program based on the patient’s 
weight and age,8 typically starting at 25 W and increasing by 
20 W each minute with cadence fixed at 60 rpm. Exercise was 
continued until the development of symptoms of myocardial 
ischemia or the limits of their performance. Patients then con-
tinued to exercise at this workload, at the same cadence and 
resistance, while nitroglycerin was administered to half the 
population (2 puffs sublingually at a total dose of 800 μg), 
and all patients were encouraged to exercise for another 2 
minutes. Exercising continuously beyond the ischemic thresh-
old has been shown to be feasible and safe.9
Data Analysis
All patients had continuous 12-lead ECG monitoring through-
out exercise, which was analyzed offline by investigators 
blinded to patient characteristics, exercise time, and hemo-
dynamic conditions. ST-segment depression was measured 80 
milliseconds after the J point.
Pulse Wave Analysis of Central Aortic 
Pressure
Central arterial pressure waveforms were obtained from the 
pressure wire positioned in the aortic root and were ana-
lyzed with the custom CardiacWaves program (King’s College 
London). The tension-time index (TTI), diastolic time index 
(DTI), Buckberg index (BI; calculated as DTI/TTI), and diastolic 
time fraction were determined, with the dicrotic notch signi-
fying the onset of diastole. Figure 1A shows a typical aortic 
pressure waveform denoting the measured metrics. TTI relates 
to myocardial oxygen demand,10 and DTI and BI relate to cor-
onary perfusion.11 The rate-pressure product was determined 
as a product of central systolic blood pressure and heart rate, 
another surrogate of myocardial oxygen consumption.12 
Augmentation index, a measure of central systolic blood 
pressure augmentation, and timing of the reflected pressure 
wave were also determined (Figure 1A). Augmentation index 
is related to arterial stiffness and likely arises from pressure 
wave reflection from the aorta, proximal elastic arteries, and 
peripheral muscular arteries.13 Left ventricular (LV) ejection 
time was measured from the upstroke of the arterial tracing 
until the trough of the dicrotic notch.
Coronary Artery Hemodynamics
Mean coronary blood flow velocity (U) was determined 
from the Doppler signal distal to the coronary stenosis 
(Figure 1B). Indexes of coronary stenosis severity were cal-
culated to include stenosis resistance as (Pa–Pd)/U, where 
Pa is aortic pressure and Pd is distal coronary pressure; Pd/
Pa ratio; and change in coronary flow velocity (average peak 
velocity at each exercise time divided by baseline average 
peak velocity).14,15 Microvascular resistance was calculated 
as Pd/U.15
Wave intensity analysis was performed with established 
methodology.16–19 Further description of the technique is 
found in the Methods section and Figure I of the online-only 
Data Supplement.
The diastolic flow velocity–pressure gradient relation 
was calculated to gain further understanding of coronary 
hemodynamics with the use of established methods.20–22 An 
adjustment was made for the time delay between the digi-
tally archived pressure and velocity signals (55 milliseconds). 
Representative beats (minimum, 5) at each time point were 
chosen. For each beat, the flow velocity values from mid dias-
tole to atrial contraction were plotted against the instanta-
neous pressure gradient (Pa–Pd). The data were then fitted 
with a quadratic equation, ∆P=0+kv+Sv2, where ∆P is the 
instantaneous pressure gradient in millimeters of mercury, v is 
the coronary flow velocity in centimeters per second, k is the 
coefficient of pressure loss resulting from viscous friction, and 
S is the coefficient of pressure loss caused by flow separation 
or localized turbulence (Figure 1D).20–22 The values for k and 
S for each patient’s time point and hemodynamic condition 
were determined with the least-squares method (constrained 
to k≥0 and S≥0).
The investigators who performed the data analyses were 
blinded to all of the clinical patient data.
Statistical Analysis
Continuous variables were tested for normality with visual 
inspection (histograms and the normal Q-Q plot) and the 
Shapiro-Wilk test and expressed as mean±SEM. Repeated-
measures ANOVA was used to evaluate the main time trends 
across the exercise period. If the overall test for the main 
effect of exercise exertion reached significance in the ANOVA, 
separate time points were evaluated with paired t tests. A cor-
rection was not applied for multiple comparisons to reduce 
the chance of missing significant hemodynamic changes in 
this exploratory study (type II error). A value of P<0.05 was 
considered statistically significant. Statistical analysis was per-
formed with IBM SPSS version 21.
The study was powered to ensure that there was a suf-
ficient number of patients to detect an attenuation of angina 
with the administration of nitroglycerin measured by 1 mm 
of ST-segment shift. On the basis of the results of a similar 
study from our institution evaluating warm-up angina,23 this 
gave a sample size of 18 patients in each group to achieve 
99% power with a probability of a type 1 error of 0.001. This 
level of power was chosen because it was likely that multiple 
hemodynamic variables contributed to the effects of nitro-
glycerin and their variance was possibly greater than that of 
the ST-segment shift.
RESULTS
Forty patients (34 male; age, 65.2±7.6 years) complet-
ed the protocol, 21 in the nitroglycerin group and 19 in 
the control group. A total of 56 patients consented to 
the study but did not complete the protocol. Reasons 
for noncompletion were as follows: 9 had left main 
or 3-vessel disease, 4 had chronic total occlusions, 20 
had angiographically normal or only minor disease, 3 
experienced radial spasm necessitating use of nitroglyc-
erin, 3 were unable to cycle, 3 had very tight lesions 
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where flow was compromised on passing of the wire 
necessitating immediate percutaneous coronary inter-
vention, and 4 had taken nitrates tablets, 5 had taken 
β-blockers, and 2 had taken a calcium channel antago-
nist within 48 hours of the study. Three patients had 
their research procedures canceled because of a medi-
cal emergency in another patient.
Baseline demographics of those who completed the 
study and procedural details are summarized in Tables 1 
and 2. Patients in the control and nitroglycerin groups 
were well matched. Exercise power output and mea-
sured ST-segment deviation are summarized in Figure 2. 
There was a progressive increase in ergometer resis-
tance toward peak exercise, which was maintained at 
the same workload for a further 2 minutes of exercise 
in both groups. Limiting symptoms at peak exercise are 
summarized in Table 3. Despite similar external work in 
both groups, after nitroglycerin administration, there 
was a significant attenuation in ST-segment depression. 
At rest, the ST segments in the territories subtended by 
the coronary artery lesion were isoelectric, and progres-
sive ST-depression was seen (0.164±0.026 mV for the 
nitroglycerin group, 0.169±0.021 mV for the control 
group; P=0.836) at peak exercise, consistent with sig-
nificant ischemia (P<0.0001). In the control group, there 
was numerical worsening of ST-segment depression 
(P=0.355) as patients exercised from the peak period 
to 2 minutes after nitroglycerin administration, whereas 
those who received nitroglycerin had improvement in 
ST-segment depression to 0.119±0.021 mV (P=0.003). 
Figure  3 shows a significant and similar increase in 
heart rate with exercise between study arms. Systolic 
blood pressure increased significantly with exercise 
(P<0.0001), with a significant reduction seen 2 minutes 
after nitroglycerin administration (P=0.030), whereas 
the control group had no significant change (P=0.978). 
Consequently, the rate-pressure product increased sig-
nificantly with exercise in both groups (P<0.0001) but 
decreased significantly after nitroglycerin (P<0.046).
Parameters related to wave reflection, DTI, TTI, and 
BI are summarized in Figure 4. There was no significant 
change in TTI during incremental exercise (P=0.386) 
because heart rate and blood pressure increased to-
gether. However, after nitroglycerin, there was a sig-
nificant reduction in TTI compared with peak exercise 
(P=0.024) because systolic blood pressure and augmen-
Figure 1. Aortic and coronary signals.  
A, Pressure waveform recorded from the ascending aorta from a study patient. Two systolic peaks are labeled P1 and P2. 
Augmentation index is calculated as augmented pressure (P2−P1) as a percentage of total pulse pressure, P1. The time to the 
reflected wave from the foot of the pressure tracing to the inflection point is shown as TR. The area under the curve during sys-
tole is the tension-time index (TTI), and the area under diastole is the diastolic time index (DTI). Buckberg index is calculated as 
BI=DTI/TTI. B, Typical coronary pressure and flow velocity recordings. C, Ensemble-averaged pressure and flow velocity signals 
(blue lines indicate pressure; red line indicates flow velocity). D, The diastolic velocity–pressure gradient relationship, expressed 
as raw signals, is shown (bottom left), with the data fitted with a quadratic equation ∆P=0+kv+Sv2, where ∆P is the instan-
taneous pressure gradient (mm Hg), v is the coronary flow velocity (cm/s), k is the coefficient of pressure loss resulting from 
viscous friction, and S is the coefficient of pressure loss caused by flow separation or localized turbulence.
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tation index fell. Timing of the reflected pressure wave 
shortened with exercise (P=0.004) but did not signifi-
cantly change in the peak period, and changes were 
similar in both groups. There was no significant change 
in augmentation index to 50% of peak exercise, but 
significant reductions were seen as exercise continued 
regardless of treatment group (P=0.014 for the nitro-
glycerin group; P=0.033 for the control), contributing 
to a reduction in afterload. LV ejection time, DTI, BI, 
and diastolic time fraction all decreased significantly 
with exercise (P<0.05), consistent with increased myo-
cardial oxygen demand and reduced perfusion. After 
nitroglycerin, there was a significant increase in BI at 2 
minutes after administration (P=0.0171) and in diastolic 
time fraction (P=0.0260), consistent with improvement 
in myocardial oxygen supply.
Intracoronary pressure gradient and flow velocity are 
shown in Figure 5. There were trends toward worsen-
ing of stenosis severity measured by Pd/Pa, as well as 
an increase in stenosis resistance, but the changes did 
not reach statistical significance. Coronary flow veloc-
ity increased during exercise, but changes were not 
significant. Similarly, microvascular resistance reduced 
numerically during exercise, but the difference did not 
reach statistical significance. Results of the wave inten-
Table 1. Baseline Demographics
Variable
Nitroglycerin 
Group (n=21)
Control 
Group 
(n=19)
P 
Value
Male 18 (85.7) 16 (84.2) 0.63
Mean age (SD), y 66.5 (5.7) 63.7 (8.2) 0.78
Body mass index, kg/m2 29.7 (4.5) 28.6 (4.2) 0.86
Previous myocardial infarction 2 (10) 1 (5) 0.55
Previous percutaneous coronary 
intervention
6 (29) 5 (26) 0.87
Diabetes mellitus 5 (24) 6 (32) 0.58
Hypertension 13 (62) 10 (53) 0.55
Dyslipidemia 18 (86) 14 (74) 0.34
Family history of ischemic heart 
disease
11 (52) 9 (47) 0.32
Smoker 7 (33) 5 (26) 0.63
β-Blocker 10 (48) 11 (58) 0.52
Nitrate 5 (24) 8 (42) 0.22
ACEi/ARB 15 (71) 11 (58) 0.37
Statin 19 (90) 18 (95) 0.99
Calcium channel blocker 8 (38) 6 (32) 0.66
Nicorandil 2 (10) 3 (16) 0.55
Aspirin 19 (90) 19 (100) 0.17
Clopidogrel 9 (43) 7 (37) 0.70
Values indicate n (%), unless otherwise stated. ACEi indicates angiotensin-
converting enzyme inhibitor; and ARB, angiotensin II receptor antagonist.
Figure 2. Supine exercise resistance protocol and ST-
segment change. 
Top, Exercise performance summarized cycling resistance 
in Watts with patients cycling at 60 rpm, at baseline (Base), 
50% of the time (t50) to peak exercise (peak) when patients 
experienced significant limiting symptoms, and continued 
exercise 1 and 2 minutes after peak. At time peak, half the 
patients had sublingual nitroglycerin (GTN) administered, 
and all patients continued to exercise for an extra 2 minutes 
at the same workload. Bottom, The mean surface ECG 
ST-segment deviation in millivolts. *Statistical significance, 
baseline vs peak exercise, P<0.05. ‡Significant difference, 
peak after nitroglycerin (GTN) vs control.
Table 2. Procedural Details
Variable
Nitroglycerin 
Group (n=21)
Control 
Group (n=19)
P 
Value
Diseased vessels per patient, n 1.4±0.6 1.6±0.8 0.84
Stenosis of target lesion, % 71.5±19.3 73.5±18.9 0.94
Target lesion PCI, n (%) 16 (76) 15 (79) 0.83
Vessel (LAD/LCx/RCA), n 13/3/5 9/1/6  
Duration of procedure, min 61.4±11.9 57.4±10.8 0.81
Exercise duration to peak, s 321.2±105.5 312.7±96.5 0.41
Postpeak exercise duration, s 116.9±7.7 106.9±9.4 0.94
LAD indicates left anterior descending coronary artery; LCx, left circumflex 
coronary artery; PCI, percutaneous coronary intervention; and RCA, right 
coronary artery.
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sity analysis are presented in Figure II in the online-only 
Data Supplement.
Figure 6 shows the diastolic velocity–pressure gradi-
ent relation. Figure 6A shows a representative example 
of the raw data plotted for 2 exercise time points in 1 
study, at peak and at 50% of peak exercise, for which 
the regression lines are plotted. Figure 6B shows an ag-
gregate of all the patient studies at each exercise time 
point between the 2 groups. Table 4 shows a summary 
of the corresponding k and S coefficients calculated for 
each time point. The k coefficient was found to be sig-
nificantly increased between baseline and peak exercise 
across both groups (P<0.0001). However, there were 
no significant differences between peak exercise and 
beyond, both within the control group and in those 
receiving nitroglycerin. The changes seen in the S co-
efficient did not reach statistical significance, although 
there are a consistent numeric increase during exercise 
and a reduction 2 minutes after nitroglycerin adminis-
tration compared with peak.
DISCUSSION
This study has shown that a catheterization labora-
tory exercise protocol provides a paradigm with which 
the physiology of ischemia and the performance of 
antianginals can be studied. In patients with exercise-
induced angina, administration of nitroglycerin causes 
changes in both the systemic and coronary circulation 
that combine to alleviate ischemia.
The main findings of the study are that (1) nitroglyc-
erin causes significant reduction in afterload, thereby re-
ducing myocardial oxygen demand; (2) exercise causes 
reduced peripheral arterial wave reflection, which is 
not further augmented by the administration of ni-
troglycerin; (3) exercise causes vasoconstriction of ste-
nosed epicardial segments, increasing relative stenosis 
severity; (4) nitroglycerin has the effect of vasodilating 
stenosed segments, thereby reducing relative stenosis 
severity; and (5) administration of nitroglycerin during 
exercise-induced ischemia maintains coronary pressure 
and increases coronary flow, despite a significant reduc-
tion in systemic pressure and afterload.
Myocardial Oxygen Consumption
Our findings suggest that nitroglycerin reduces oxygen 
consumption by attenuating myocardial work with a 
reduction in rate-pressure product and TTI. Another 
major determinant of myocardial oxygen consumption 
is LV afterload, determined by aortic pressure and the 
effects of arterial wave reflection. Our results show that 
there is indeed a significant reduction in arterial pres-
sure augmentation with exercise and further reduction 
with nitroglycerin, suggesting that both contribute to 
reductions in afterload by affecting the peripheral arte-
rial circulation.
Myocardial Perfusion
The hypothesis that nitroglycerin improves oxygen de-
livery to ischemic tissue by increasing total myocardial 
blood flow or by producing a redistribution of flow 
Table 3. Limiting Symptoms on Exercise
Limiting Symptom
Nitroglycerin Group 
(n=21), n (%)
Control Group 
(n=19), n (%)
Chest pain 5 (24) 7 (38)
Chest tightness 5 (24) 4 (21)
Breathless and chest pain 4 (19) 3 (16)
Breathless 1 (5) 2 (11)
Physical exhaustion 5 (24) 3 (16)
Leg cramp 1 (5) 0 (0)
Figure 3. Hemodynamics on exercise.  
Systemic hemodynamic parameters of heart rate, mean 
aortic pressure, and rate-pressure product (RPP) during study 
protocol. BP indicates blood pressure; and GTN, nitroglyc-
erin. *Statistical significance, baseline vs peak exercise, 
P<0.05. †Statistically significant difference between peak 
and 2 minutes after peak.
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has existed since the 1960s.24 The increase in the BI 2 
minutes after nitroglycerin administration suggests an 
improvement in myocardial perfusion. The coronary 
indexes, including Pd/Pa and stenosis resistance, that 
have utility in the clinical arena in the assessment of le-
sion severity do not provide significant insight into the 
coronary hemodynamics in this study. To fully interpret 
and understand the dynamics of the coronary circula-
tion, it is important to evaluate the physiology of the 
epicardial coronary arteries either side of the stenosis, 
the behavior of the stenosis itself, and the distal micro-
circulation.
Pioneering work by Gould20 and subsequently de-
veloped by Marques et al21 in describing the diastolic 
flow velocity–pressure gradient relationship gives some 
insight into the mechanisms at play. The coefficient k 
provides an estimate of the pressure loss resulting from 
viscous friction in the stenotic segment and is depen-
Figure 4. Indexes of wave reflection and beat cycle physiology.  
Systemic hemodynamic augmentation index, time to the reflected wave, tension-time index, diastolic time fraction, left ven-
tricular (LV) ejection time, and Buckberg index. GTN indicates nitroglycerin. *Statistical significance, baseline vs peak exercise, 
P<0.05. †Statistical significance, peak exercise vs 2 minutes after nitroglycerin administration, P<0.05. ‡Significant difference, 
peak exercise after nitroglycerin administration vs control.
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dent on lesion length and relative and absolute per-
centage stenosis. In this study, the k coefficient is seen 
to increase significantly during exercise. This suggests 
that the geometry of the coronary lesion changes and is 
consistent with a net worsening of lesion severity with 
exercise. Important work by Gordon and colleagues25 
who exercised patients with coronary artery disease 
showed that the anatomic changes on x-ray angiog-
raphy in response to exercise were dependent on ath-
erosclerotic disease burden whereby stenosed and ir-
regular segments constricted and smooth, disease-free 
segments dilated. In addition, animal work in smooth 
arteries suggested dilatation of smooth epicardial seg-
ments in response to exercise.26 As this occurs, the S 
coefficient, which is dependent on the relative percent-
age stenosis and the divergent angle of the stenosis, 
increases. Although not reaching statistical signifi-
cance, the trends seen in changes in the S coefficient 
in this study would support this mechanism. Therefore, 
the likely unifying coronary mechanism explaining the 
hemodynamic changes during exercise is that relative 
stenosis severity increases because of vasoconstriction 
of the diseased stenotic segments; some vasoconstric-
tion of adjacent irregular, atherosclerotic segments; and 
vasodilation of the normal segments. Consequently, ni-
troglycerin has the effect of reducing relative stenosis 
severity by vasodilating the stenosed and adjacent epi-
cardial segments.
It is important to note that these changes in coronary 
geometry would have a significant impact on coronary 
flow, which is not appreciated by the measurement of 
flow velocity. Our results therefore show that the main 
effect of nitroglycerin is to maintain distal coronary 
pressure and to increase coronary flow in the face of 
reducing aortic pressure and afterload.
The observed worsening of stenosis severity during 
exercise is likely to be a critical component of exertional 
symptomatology. This lesion “tone” with exercise may 
well vary between patients and is unlikely to be picked 
up by modern catheter-based assessments of lesion se-
verity such as fractional flow reserve27,28 in which the 
administration of adenosine does not change relative 
stenosis severity. Methods of assessing lesion tone may 
prove useful in the management of patients with dem-
onstrated coronary artery disease.
A further mechanism responsible for enhanced sub-
endocardial perfusion with nitroglycerin is the transmu-
ral redistribution of coronary blood flow resulting from 
increased diastolic relaxation/delayed systolic compres-
sion, as evidenced by the reduced TTI and increased 
diastolic time fraction and BI after nitroglycerin admin-
istration. This is consistent with nuclear studies suggest-
ing that nitrates preferentially redistribute blood to the 
subendocardium from the subepicardium.29–31 This is 
likely a critical mechanism in reducing ischemia because 
the autoregulatory mechanisms controlling myocardial 
blood flow can become exhausted during exercise, ren-
dering the subendocardial layer critically dependent on 
diastolic time fraction.20
Peripheral Wave Reflection
The effects of exercise in reducing wave reflection in 
the aortic pressure waveform have been previously de-
scribed and are due to vasodilatation of the systemic 
muscular arteries.5,23,32 These effects were almost iden-
tical to those seen after the administration of nitroglyc-
erin.5 Our study demonstrates that there is no additional 
reduction in arterial wave reflection when nitroglycerin 
is given during peak exercise, suggesting that it is likely 
to be governed by the same pathway.
Limitations
This is a small, single-center study, but it is the first to ex-
amine the effects of nitroglycerin by integrating invasive 
central aortic and coronary hemodynamics during physi-
ological exercise in patients with coronary artery dis-
ease. A protocol in which patients continued to exercise 
at ischemia/near-maximal exertion was used but was 
feasible to maintain this effort only to ≈2 minutes. The 
effects of sublingual nitroglycerin are known to persist 
beyond this time; therefore, our study has the potential 
to have missed these changes. However, the majority of 
the hemodynamic effects would be expected to have 
occurred within the first 2 minutes of administration.33
Figure 5. Coronary hemodynamics.  
Mean distal pressure (Pd) to aortic pressure (Pa) ratio and 
relative change in coronary flow velocity as a ratio of aver-
age peak velocity at individual time points vs baseline. GTN 
indicates nitroglycerin; and t50, 50% of peak exercise.
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As stated in the Methods, the 2 groups of patients 
were recruited sequentially and were not randomized; 
therefore, an element of bias cannot be excluded. The 
fact that the groups are similar on baseline and pro-
cedural factors gives some reassurance, although this 
remains a limitation.
The aortic and coronary hemodynamics described in 
this work suggest direct effects of exercise and nitro-
glycerin on epicardial coronary artery geometry. It was 
not possible to directly perform coronary angiography 
during the exercise protocol to allow quantitative as-
sessment of arterial size. In practical terms, the guiding 
catheter was disengaged from the coronary ostium to 
prevent catheter-induced trauma during the inevitable 
movement that occurs in the arm and body during ex-
ercise. In addition, injecting contrast medium into coro-
nary arteries gives a short ischemic insult that may have 
affected the measurements.
We did not measure LV pressure or mechanics and 
therefore cannot exclude important changes that may 
have contributed. Furthermore, we used established sur-
rogates of myocardial oxygen consumption and were not 
able to measure this directly. Although the measurement 
of LV mechanics and direct measurement of oxygen con-
sumption would provide more definitive mechanistic 
insight, it was not feasible to take such measurements 
given the complexity of the protocol already in place.
Conclusions
In patients with exertional angina and severe coronary 
artery disease studied during limiting exercise, nitro-
Figure 6. Diastolic coronary velocity–pressure gradient relation.  
Top, Two time points: 50% of peak exercise (t50) and peak exercise recordings in 1 individual. Bottom, Regression lines that 
arise from aggregating the k and S coefficients from recordings in all patients. Solid lines represent the control group; dashed 
lines, those who received nitroglycerin (GTN). Black line indicates baseline; blue, t50; red, peak; purple, 1 minute after peak; 
and green, 2 minutes after peak. *Statistically significant difference vs baseline of the k coefficient (Table 4 lists all the coef-
ficients).
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glycerin produces several changes in systemic, coronary, 
and LV hemodynamics that combine to reduce ischemia 
and to enhance cardiac performance. This protocol 
provides a new paradigm with which the physiology of 
ischemia and the performance of novel and established 
antianginals can be studied.
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